Literature DB >> 2940470

Evidence that transmissible mink encephalopathy agent is biologically inactive in mice.

D M Taylor, A G Dickinson, H Fraser, R F Marsh.   

Abstract

Transmissible mink encephalopathy (TME) is probably a form of the sheep disease, scrapie, introduced by accidentally feeding mink with scrapie-infected sheep tissues. Although no successful transmissions of TME to mice have been achieved previous work has involved various limitations. To maximize the possibility of transmission, 176 mice, representing 14 different genotypes mostly not previously tested with TME, were injected with TME-infected mink brain from three sources with different histories. No scrapie-like disease was detected clinically or histologically in these mice or in a further 111 which were subsequently injected with brain or spleen material from 10 of the TME-injected mice killed when senile. Furthermore, a series of experiments involving seven strains of scrapie, demonstrated that prior injection of mice with TME failed to affect the normal progress of scrapie infection indicating that TME agent had not occupied scrapie replication sites or otherwise influenced the pathogenesis of scrapie. The overall conclusion from these experiments is that TME is biologically inactive in mice. Although many strains of natural scrapie can be transmitted to laboratory mice, this has not been possible with all strains and it is concluded that one or more of such strains is likely to be the cause of TME in mink.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2940470     DOI: 10.1111/j.1365-2990.1986.tb00051.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  12 in total

1.  Breaking an absolute species barrier: transgenic mice expressing the mink PrP gene are susceptible to transmissible mink encephalopathy.

Authors:  O Windl; M Buchholz; A Neubauer; W Schulz-Schaeffer; M Groschup; S Walter; S Arendt; M Neumann; A K Voss; H A Kretzschmar
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

Review 2.  Prion Strain Diversity.

Authors:  Jason C Bartz
Journal:  Cold Spring Harb Perspect Med       Date:  2016-12-01       Impact factor: 6.915

3.  Long-term subclinical carrier state precedes scrapie replication and adaptation in a resistant species: analogies to bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease in humans.

Authors:  R Race; A Raines; G J Raymond; B Caughey; B Chesebro
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

4.  Prion interference is due to a reduction in strain-specific PrPSc levels.

Authors:  Jason C Bartz; Michelle L Kramer; Meghan H Sheehan; Jessica A L Hutter; Jacob I Ayers; Richard A Bessen; Anthony E Kincaid
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

5.  Nonpathogenic Heterologous Prions Can Interfere with Prion Infection in a Strain-Dependent Manner.

Authors:  Alba Marín-Moreno; Patricia Aguilar-Calvo; José Luis Pitarch; Juan Carlos Espinosa; Juan María Torres
Journal:  J Virol       Date:  2018-11-27       Impact factor: 5.103

6.  Experimental infection of sheep and goats with transmissible mink encephalopathy virus.

Authors:  W J Hadlow; R E Race; R C Kennedy
Journal:  Can J Vet Res       Date:  1987-01       Impact factor: 1.310

7.  Host Determinants of Prion Strain Diversity Independent of Prion Protein Genotype.

Authors:  Jenna Crowell; Andrew Hughson; Byron Caughey; Richard A Bessen
Journal:  J Virol       Date:  2015-08-05       Impact factor: 5.103

Review 8.  Environmental and host factors that contribute to prion strain evolution.

Authors:  Jason C Bartz
Journal:  Acta Neuropathol       Date:  2021-04-25       Impact factor: 17.088

9.  Phenotypic similarity of transmissible mink encephalopathy in cattle and L-type bovine spongiform encephalopathy in a mouse model.

Authors:  Thierry Baron; Anna Bencsik; Anne-Gaëlle Biacabe; Eric Morignat; Richard A Bessen
Journal:  Emerg Infect Dis       Date:  2007-12       Impact factor: 6.883

Review 10.  The role of prion strain diversity in the development of successful therapeutic treatments.

Authors:  Sara A M Holec; Alyssa J Block; Jason C Bartz
Journal:  Prog Mol Biol Transl Sci       Date:  2020-08-28       Impact factor: 3.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.